Search

everythinglearnresearchcommunity

for

Search:↓

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

GLP1-RAs may have higher reports of suicidal events and hair loss compared to other diabetes drugs.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Weight-loss drugs are not linked to suicidal thoughts.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Lifestyle changes are more effective than metformin in reducing type 2 diabetes risk in women with PCOS.

Metformin and liraglutide improved symptoms of HAIR-AN syndrome in a child.

Metformin and thiazolidinediones are similarly effective for PCOS, but metformin is often preferred due to fewer side effects.

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.

Topical sulfonylurea may reduce excessive hair growth caused by certain medications.

Linagliptin may cause hair loss and skin blisters.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Targeted drug delivery to pancreatic beta-cells can improve type 2 diabetes treatment.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

SGLT2 inhibitors may help manage PCOS symptoms effectively.

Semaglutide is an effective weekly treatment for obesity, promoting weight loss and improving health, despite some side effects.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

Finasteride may worsen blood sugar control in diabetic patients.

Liraglutide with metformin reduces body fat and improves blood sugar control better than metformin and inositol in women with prediabetes.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.

GLP-1 agonists may increase the risk of hair loss.

Topical metformin shows promise for dental and skin treatments, including periodontitis, hair regrowth, wound healing, and acne.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Tridax procumbens significantly lowers blood sugar in diabetic rats.